The Human Microbiome Across Body Sites: Gut, Skin, Oral, Vaginal and Lung

What the microbiome is, and how it is measured across body sites

The human microbiome is the collective genome of the trillions of bacteria, archaea, fungi and viruses that colonize the body's epithelial surfaces. It is not a single organ-like community but a mosaic of site-specific ecosystems, each shaped by the local temperature, pH, oxygen tension, moisture and nutrient supply of its niche. Large surveys such as the NIH Human Microbiome Project established that the gut, skin, oral cavity, airway and vaginal tract each harbor characteristic, reproducible microbial assemblages.

Modern characterization relies on culture-independent sequencing: 16S rRNA gene amplicon profiling to catalog which taxa are present, and shotgun metagenomics to resolve strains and functional gene content. Metatranscriptomics, metabolomics and metaproteomics add information on what the community is actually doing. Because low-biomass sites such as the lung are easily overwhelmed by contamination, careful controls are essential to distinguish a true resident community from sequencing artifacts.

Comprehensive syntheses such as Hou and colleagues' 2022 review in Signal Transduction and Targeted Therapy, and the Human Microbiome Action Consortium's 2024/2025 Nature Reviews Microbiology analysis of the healthy-microbiome concept, frame the modern view: there is no single universal healthy microbiome, only ranges of composition and function compatible with health at each body site.

The major body-site niches and their signature communities

The gut, and particularly the colon, hosts the densest and most diverse microbial community in the body, dominated by the phyla Bacillota (Firmicutes) and Bacteroidota (Bacteroidetes). Its residents ferment dietary fiber into short-chain fatty acids such as butyrate, synthesize vitamins, resist pathogen colonization and continuously educate the immune system. Diversity here is generally interpreted as a marker of stability and resilience.

The skin is a cool, dry, nutrient-poor surface whose communities track the local microenvironment: sebaceous sites favor lipophilic Cutibacterium, moist folds favor Staphylococcus and Corynebacterium. The oral cavity is a set of distinct surfaces (tongue, teeth, gingiva, saliva) supporting structured biofilms rich in Streptococcus, Veillonella, Neisseria and Fusobacterium. The vaginal microbiome of most reproductive-age women is low in diversity and dominated by Lactobacillus species, whose lactic-acid production keeps the pH low and suppresses pathogens; a shift away from this state is a recognized risk marker. The healthy lung, once thought sterile, carries a sparse, low-biomass community continuously seeded by microaspiration from the mouth and cleared by mucociliary transport.

A defining feature is individuality and biogeography: two people differ far more in the exact strains they carry than in the broad functions those strains provide, and communities cluster far more tightly by body site than by person. Function is more conserved than membership.

How microbiomes are acquired, transmitted and restored

Colonization begins at or near birth and is heavily shaped by the mother. Delivery mode, breastfeeding, early diet, antibiotics and household environment all steer the assembling gut community through infancy toward an adult-like state. Person-to-person strain sharing is now measurable: work reviewed by Heidrich, Valles-Colomer and Segata (Nature Reviews Microbiology, 2025) shows substantial mother-to-infant gut transmission that persists into childhood, plus meaningful intra-household and intra-population sharing across the gut and oral microbiomes.

Disruption of these communities is termed dysbiosis, a loss of the diversity, composition or function associated with health. Dysbiosis at each site tracks with disease: gut dysbiosis with inflammatory bowel disease, obesity, and metabolic and immune disorders; oral dysbiosis with periodontitis and caries; vaginal dysbiosis with bacterial vaginosis and adverse reproductive outcomes; airway dysbiosis with asthma and chronic obstructive pulmonary disease.

Restoration strategies aim to rebuild a health-associated community. Dietary fiber and prebiotics, probiotics, and fecal microbiota transplantation (FMT) are the leading approaches; FMT is notably effective against recurrent Clostridioides difficile infection. These interventions underscore that the microbiome is modifiable, and therefore a plausible mediator between environmental exposures and disease.

The mechanism: metals as a currency at the host-microbe interface

Trace metals are contested resources at every microbial niche. Iron, zinc, manganese and copper are essential cofactors that both host cells and microbes require, so the host actively withholds them to limit microbial growth, a defense called nutritional immunity. In the gut, neutrophil-derived calprotectin sequesters manganese and zinc, and lipocalin-2 blocks bacterial siderophores that scavenge iron. Microbes counter with their own siderophores and metallophores and with tightly tuned metalloregulation to maintain metallostasis. The balance of this metal tug-of-war helps determine which taxa flourish.

Toxic metals intrude on the same chemistry. Lead, cadmium, arsenic and mercury can mismetallate microbial and host metalloproteins, generate oxidative stress, and impose selective pressure that favors metal-tolerant, often opportunistic organisms while disadvantaging metal-sensitive commensals. Because much ingested metal transits and interacts with the gut before absorption, the gut microbiome is both an early target and a modifier of metal toxicity.

Fitting the pieces together: the metal-microbiome-disease axis

A 2025 systematic review by Rezazadegan and colleagues in the Journal of Health, Population and Nutrition synthesized human studies of the major toxic metals and gut-microbiota composition. Across studies, higher exposure to lead, arsenic and mercury was associated with expansion of pathobionts such as Collinsella and, for arsenic, of Proteobacteria and Enterobacteriaceae, alongside reductions in beneficial Bifidobacterium and Bacteroides. The authors concluded that heavy-metal exposure disturbs gut-microbiota composition and can drive dysbiosis, though data for some metals (notably cadmium and mercury) remain limited and heterogeneous.

These findings supply the mechanistic bridge behind the metal-microbiome-disease axis: metal exposure reshapes the microbiome, and microbiome disruption is itself linked to inflammatory, metabolic and immune disease. Consistent with this, the same literature reports that metal-associated dysbiosis coincides with impaired gut-barrier integrity, or leaky gut, allowing microbial products to enter the circulation and fuel systemic inflammation.

The evidence to date is largely associative, and disentangling metals from co-exposures, diet and confounding remains an active challenge. Stated carefully, the human microbiome is a biologically plausible, partly measurable pathway through which heavy-metal exposure could contribute to disease; it is not yet a proven single cause. Read alongside the body-site map above, it explains why the microbiome sits at the center of this site's editorial thesis.